Detalhe da pesquisa
1.
Use of once-daily oral semaglutide and associated clinical outcomes among adults with type 2 diabetes in routine clinical practice in Canada: A multicentre, prospective real-world study (PIONEER REAL Canada).
Diabetes Obes Metab
; 26(5): 1799-1807, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38468125
2.
Switching between GLP-1 receptor agonists in clinical practice: Expert consensus and practical guidance.
Int J Clin Pract
; 75(2): e13731, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32975890
3.
Comparison of the efficacy and safety of ultrasound-guided core needle biopsy versus fine-needle aspiration for evaluating thyroid nodules.
Endocr Pract
; 21(2): 128-35, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25297665
4.
Glycemic improvement with a novel interim intervention technique using retrospective professional continuous glucose monitoring (GLITTER study): A study from Mumbai, India.
Diabetes Metab Syndr
; 15(3): 703-709, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33813245
5.
Real-World Effectiveness Analysis of Switching From Liraglutide or Dulaglutide to Semaglutide in Patients With Type 2 Diabetes Mellitus: The Retrospective REALISE-DM Study.
Diabetes Ther
; 12(2): 527-536, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33367981
6.
7.
Use of flash glucose monitoring is associated with HbA1c reduction in type 2 diabetes managed with basal insulin in Canada: A real-world prospective observational study.
Diab Vasc Dis Res
; 21(3): 14791641241253967, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38733368
8.
Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384-390.
Diabetes Care
; 46(5): e117, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37185678
9.
Diabetes and Mental Health.
Can J Diabetes
; 47(4): 308-344, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37321702